SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-21-008965
Filing Date
2021-12-03
Accepted
2021-12-03 16:01:16
Documents
14
Period of Report
2021-11-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K curr_8k.htm   iXBRL 8-K 20833
  Complete submission text file 0001477932-21-008965.txt   134130

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA curr-20211129.xsd EX-101.SCH 5595
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE curr-20211129_lab.xml EX-101.LAB 13282
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE curr-20211129_cal.xml EX-101.CAL 890
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE curr-20211129_pre.xml EX-101.PRE 8364
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE curr-20211129_def.xml EX-101.DEF 2097
7 EXTRACTED XBRL INSTANCE DOCUMENT curr_8k_htm.xml XML 3287
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55908 | Film No.: 211469925
SIC: 2834 Pharmaceutical Preparations